Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$596M |
| 2 |
Meta Platforms (Facebook)
META
|
+$524M |
| 3 |
Microsoft
MSFT
|
+$415M |
| 4 |
Dominion Energy
D
|
+$358M |
| 5 |
Amazon
AMZN
|
+$358M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HEICO Corp Class A
HEI.A
|
+$764M |
| 2 |
Vale
VALE
|
+$427M |
| 3 |
SIVB
SVB Financial Group
SIVB
|
+$397M |
| 4 |
NBIS
Nebius Group N.V.
NBIS
|
+$376M |
| 5 |
ONC
BeOne Medicines Ltd
ONC
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.68% |
| 2 | Healthcare | 12.92% |
| 3 | Financials | 11.76% |
| 4 | Industrials | 11.1% |
| 5 | Consumer Discretionary | 10.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3526
MBIA
MBI
$275M
| $153K | ﹤0.01% |
16,547
-33,675
| -67% | -$402K |
|
3527
GoodRx Holdings
GDRX
$1.09B
| $151K | ﹤0.01% |
24,108
-8,714
| -27% | -$48.6K |
|
|
BASE
3528
DELISTED
Couchbase
BASE
| $150K | ﹤0.01% |
+10,703
| New | +$158K |
|
|
HDSN
3529
Hudson Technologies
HDSN
$246M
| $149K | ﹤0.01% |
17,103
-22,873
| -57% | -$221K |
|
|
YI
3530
111 Inc
YI
$31.3M
| $149K | ﹤0.01% |
5,607
-385
| -6% | -$11.3K |
|
|
CTIC
3531
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $148K | ﹤0.01% |
35,244
+392
| +1% | +$2.04K |
|
3532
Barclays
BCS
$87.8B
| $148K | ﹤0.01% |
+20,574
| New | +$170K |
|
|
DPG
3533
Duff & Phelps Utility and Infrastructure Fund
DPG
$524M
| $147K | ﹤0.01% |
11,062
+34
| +0.3% | +$462 |
|
|
GRCL
3534
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $146K | ﹤0.01% |
+78,671
| New | +$164K |
|
|
IGMS
3535
DELISTED
IGM Biosciences
IGMS
| $144K | ﹤0.01% |
+10,490
| New | +$217K |
|
|
HIE
3536
DELISTED
Miller/Howard High Income Equity Fund
HIE
| $144K | ﹤0.01% |
+14,318
| New | +$151K |
|
3537
Inspired Entertainment
INSE
$183M
| $143K | ﹤0.01% |
11,163
-4,946
| -31% | -$71.3K |
|
3538
Arbutus Biopharma
ABUS
$847M
| $142K | ﹤0.01% |
46,955
+1,596
| +4% | +$4.5K |
|
3539
Kiniksa Pharmaceuticals
KNSA
$6.23B
| $141K | ﹤0.01% |
13,109
-200,449
| -94% | -$2.64M |
|
3540
Precigen
PGEN
$1.94B
| $139K | ﹤0.01% |
131,072
+88,555
| +208% | +$128K |
|
3541
Nuveen Real Estate Income Fund
JRS
$251M
| $138K | ﹤0.01% |
18,495
-28,838
| -61% | -$234K |
|
3542
Senseonics Holdings Inc
SENS
$254M
| $138K | ﹤0.01% |
9,695
+473
| +5% | +$9.5K |
|
3543
MiMedx Group
MDXG
$630M
| $137K | ﹤0.01% |
40,259
-47,524
| -54% | -$184K |
|
3544
Codexis
CDXS
$158M
| $137K | ﹤0.01% |
33,116
+2,181
| +7% | +$11.4K |
|
3545
Aspen Aerogels
ASPN
$339M
| $135K | ﹤0.01% |
18,142
+3,949
| +28% | +$39.3K |
|
|
MRSN
3546
DELISTED
Mersana Therapeutics
MRSN
| $135K | ﹤0.01% |
1,312
-19
| -1% | -$2.67K |
|
|
AGD
3547
abrdn Global Dynamic Dividend Fund
AGD
$313M
| $135K | ﹤0.01% |
14,441
-1,798
| -11% | -$17.3K |
|
3548
Evolus
EOLS
$397M
| $135K | ﹤0.01% |
15,909
+567
| +4% | +$5.13K |
|
|
BCOV
3549
DELISTED
Brightcove, Inc.
BCOV
| $133K | ﹤0.01% |
29,856
-38,289
| -56% | -$214K |
|
3550
Vuzix
VUZI
$178M
| $131K | ﹤0.01% |
31,621
-15,078
| -32% | -$67.8K |
|
Similar funds
Invesco's Q1 2023 Portfolio in Review
As of Q1 2023, Invesco held 4,112 positions worth $358B, up 5% from $341B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Invesco's Q1 2023 filing shows 101 new, 1,790 increased, 1,808 reduced and 253 closed positions. Its largest new stake was GE HealthCare: 3,173,709 shares worth $260M. The largest sale was HEICO Corp Class A, an estimated $764M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Invesco's largest Q1 2023 buy was GE HealthCare: 3,173,709 shares worth $260M.
- Invesco added most to Apple in Q1 2023, an estimated $596M increase.
- Invesco's biggest Q1 2023 reduction was HEICO Corp Class A, cutting an estimated $764M.
- Invesco fully exited SVB Financial Group in Q1 2023, selling an estimated $397M.
- Invesco's ten largest holdings make up 13% of its $358B portfolio in Q1 2023.
- Invesco opened 101 new positions and closed 253 in Q1 2023.
- Invesco's portfolio value rose 5% quarter-over-quarter to $358B.
Based on Invesco's 13F filing for Q1 2023, filed 12 May 2023.